Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China · Delayed Price · Currency is CNY 25.56
-0.03 (-0.12%)
Feb 3, 2026, 9:55 AM CST
SHA:600566 Revenue
Hubei Jumpcan Pharmaceutical had revenue of 1.18B CNY in the quarter ending September 30, 2025, a decrease of -33.17%. This brings the company's revenue in the last twelve months to 6.14B, down -31.15% year-over-year. In the year 2024, Hubei Jumpcan Pharmaceutical had annual revenue of 8.02B, down -16.96%.
Revenue (ttm)
6.14B
Revenue Growth
-31.15%
P/S Ratio
3.84
Revenue / Employee
1.22M
Employees
5,026
Market Cap
23.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.02B | -1.64B | -16.96% |
| Dec 31, 2023 | 9.65B | 658.17M | 7.32% |
| Dec 31, 2022 | 9.00B | 1.37B | 17.90% |
| Dec 31, 2021 | 7.63B | 1.47B | 23.77% |
| Dec 31, 2020 | 6.16B | -775.02M | -11.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joincare Pharmaceutical Group Industry | 15.20B |
| Livzon Pharmaceutical Group | 11.85B |
| Apeloa Pharmaceutical Co.,Ltd | 10.50B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Tasly Pharmaceutical Group | 8.35B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.02B |
| Kangmei Pharmaceutical | 5.28B |
| Chengdu Kanghong Pharmaceutical Group | 4.67B |